Purchasing Votrient doesn't have to be complicated or expensive. Ordering Votrient from Candrugstore, a trusted Canadian pharmacy, is not only more affordable but also highly convenient. You can place your order anytime—24 hours a day, seven days a week. To ensure timely delivery, which typically takes 2 to 4 weeks, it's a good idea to order early if you know you will need Votrient in the future.
Candrugstore is CIPA certified, and all our practices meet both provincial and federal regulations. This means we require a valid doctor's prescription for all orders of Votrient. Your order is sourced from trusted manufacturers such as Accord, Jamp Pharma, and other reputable generic manufacturers.
We prioritize your online security, offering a three-part BuySafe guarantee that protects you from identity theft, provides a money-back guarantee, and ensures the lowest price for your Votrient. If you find a lower price at another CIPA-certified pharmacy, we’ll match it and beat it by five dollars.
You can purchase up to a 90-day supply of Votrient to manage your medication needs. After placing your order, there's no need to pay immediately. We verify your prescription first, and a customer service representative will contact you to confirm payment
How much does Votrient cost in Canada
Here's the pricing list for Votrient at our Canadian pharmacy
Strength
Type
Quantity
Price Range (USD)
400mg
Pazopanib Hcl
30
$1009.00
Description
Indications
Pazopanib is prescribed for adults with advanced renal cell carcinoma (RCC), a cancer type originating in kidney cells. It falls under the category of medications known as kinase inhibitors, and its mechanism of action involves impeding or halting the proliferation of cancer cells.
Uses and Dosage
Pazopanib is administered in tablet form for oral consumption. Typically, it is taken once a day, on an empty stomach, either at least 1 hour before or 2 hours after a meal. To ensure optimal results, take pazopanib at approximately the same time each day.
Adhere to your doctor’s dosing guidance precisely; refrain from taking more or less of the medication or increasing the frequency beyond the prescribed regimen.
The tablets must be swallowed whole and should not be split, chewed, or crushed.
Throughout your treatment, your doctor may make adjustments to your pazopanib dosage or even discontinue the treatment, depending on its effectiveness and any side effects you may encounter.
Even if you start to feel better, continue taking pazopanib as prescribed, and do not discontinue it without consulting your doctor.
Side Effects
Some side effects may occur that usually do not need medical attention:
diarrhea
constipation
heartburn
change in ability to taste food
joint or muscle pain
swelling of the face
tender, red palms of the hands and soles of the feet
hair loss
thin, brittle fingernails or hair
change in hair color
lightening of an area of the skin
rash
weakness
depression
unusual discomfort in cold temperatures
weight loss
Inform your healthcare provider immediately if you experience any serious side effects:
fast or irregular heartbeat
chest pain
pain in the arms, back, neck or jaw
shortness of breath
headache
slow or difficult speech
dizziness or faintness
weakness or numbness of an arm or leg
wounds that do not heal
stomach pain or swelling
black and tarry stools
red blood in stools
bloody vomit
vomit that looks like coffee grounds
blood in urine
nosebleeds
coughing up blood
Caution
Prior to initiating pazopanib, disclose any allergies to your doctor or pharmacist, including allergies to pazopanib itself or any other substances. This medication may contain inactive components that can induce allergic reactions or other complications.
Before commencing this treatment, relay your medical history to your healthcare provider or pharmacist, particularly if you have a history of liver disease, chest pain, heart attack, high blood pressure, stroke, recent surgical procedures or injuries, bleeding or clotting disorders, blood vessel issues such as aneurysms or tears in major blood vessels, gastrointestinal problems like ulcers, fistulas, or pancreatitis, or an underactive thyroid.
Pazopanib has the potential to lead to a heart rhythm disorder known as QT prolongation. Although rare, this condition can result in serious, occasionally fatal, rapid or irregular heartbeat, along with symptoms like severe dizziness or fainting, necessitating immediate medical attention. A heightened risk of QT prolongation may arise if you are concurrently using specific medications like diuretics (commonly referred to as “water pills”) or if you experience conditions such as intense sweating, diarrhea, or vomiting.
This medication might cause delayed or poor wound healing. If you are scheduled for surgery, it is crucial to converse with your doctor regarding the advantages and drawbacks of continuing this medication. Your doctor may recommend a temporary halt to pazopanib treatment, typically at least one week before the surgery. Precise instructions on when to discontinue and resume pazopanib treatment should be obtained from your doctor. If you notice wounds that are not healing properly, promptly notify your doctor.
To reduce the risk of cuts, bruises, or injuries, exercise caution when using sharp objects like razors and nail clippers, and consider avoiding activities involving physical contact, such as contact sports.
Elderly individuals may exhibit heightened sensitivity to this drug’s side effects, particularly in relation to liver issues or QT prolongation.
If you are pregnant or planning to become pregnant, you must inform your doctor. A pregnancy test will be administered by your doctor before initiating treatment. Avoid becoming pregnant while undergoing pazopanib therapy, as it may pose a risk to the unborn child. Both women and men should inquire about dependable methods of birth control for use throughout the treatment period and for at least two weeks following its cessation. If you or your female partner becomes pregnant, consult your doctor regarding the medication’s risks and benefits.
The passage of this medication into breast milk remains uncertain. Given the potential risk to the infant, it is not recommended to breast-feed while using this drug and for two weeks after discontinuing treatment.
Form and Strength
Votrient is available in the following forms and strengths:
pazopanib tablet:
200mg
FAQ
Does Votrient shrink tumors?
Votrient has been shown to slow the growth and spread of renal cell carcinoma and soft tissue sarcoma. Votrient may also help shrink these types of tumors.
Is Votrient a targeted therapy?
Pazopanib is a type of targeted therapy called a tyrosine kinase inhibitor.
Prescription Required 
Formulation :
Tablet 
